Key publication
3
Therapeutic Areas
Lab methods

Key publication

Evidence of NI-0101 pharmacological activity, an anti-TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS.

Key publication

IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasis.

Key publication

Measurement of collagen- and serotonin-induced platelet aggregation in whole blood.